← Browse by Condition
Medical Condition
lymphoma t cell
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT06699771 Phase 1
Recruiting
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Enrollment
48 pts
Location
South Korea
Sponsor
GC Cell Corporation
NCT06530550 Phase 2
Recruiting
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Enrollment
51 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT03161223 Phase 1, Phase 2
Recruiting
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
Enrollment
148 pts
Location
United States
Sponsor
University of Virginia
NCT07356245 Phase 2
Recruiting
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Enrollment
44 pts
Location
United States
Sponsor
Jonathan Brammer